DK0661045T3
(da)
*
|
1992-09-18 |
2002-10-28 |
Yamanouchi Pharma Co Ltd |
Hydrogelpræparat med forsinket frigivelse
|
DE19509807A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
US5945125A
(en)
*
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
US6166024A
(en)
*
|
1995-03-30 |
2000-12-26 |
Mayo Foundation For Medical Education And Research |
Use of topical azathioprine and thioguanine to treat colorectal adenomas
|
EP0761209A3
(de)
*
|
1995-09-01 |
1998-02-04 |
J.B. Chemicals & Pharmaceuticals Ltd. |
Ranitidinformulierungen mit gesteuerter Freisetzung
|
ES2325046T3
(es)
*
|
1996-06-26 |
2009-08-24 |
The Board Of Regents, The University Of Texas System |
Formulacion farmaceutica extruible por fusion en caliente.
|
ZA976189B
(en)
*
|
1996-07-12 |
1999-01-11 |
Novartis Consumer Health Sa |
Oral pharmaceutical combinations
|
GB9720797D0
(en)
*
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
DE19901040A1
(de)
*
|
1999-01-14 |
2000-07-20 |
Knoll Ag |
Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
|
EG23951A
(en)
|
1999-03-25 |
2008-01-29 |
Otsuka Pharma Co Ltd |
Cilostazol preparation
|
WO2000074650A2
(en)
*
|
1999-06-04 |
2000-12-14 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
US20020015731A1
(en)
*
|
1999-12-23 |
2002-02-07 |
Appel Leah E. |
Hydrogel-Driven Drug Dosage Form
|
JPWO2001078681A1
(ja)
*
|
2000-04-17 |
2004-01-08 |
山之内製薬株式会社 |
薬物動態学的な薬物相互作用を回避する薬物送達システム及びその方法
|
US20020028240A1
(en)
*
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
US6419954B1
(en)
*
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
PE20030527A1
(es)
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
KR101016619B1
(ko)
*
|
2001-11-13 |
2011-02-23 |
아스텔라스세이야쿠 가부시키가이샤 |
용해성 약물 지속 방출 시스템
|
CA2474838C
(en)
*
|
2002-02-01 |
2009-01-06 |
Pfizer Products Inc. |
Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
|
AU2003211267A1
(en)
*
|
2002-02-27 |
2003-09-09 |
Shionogi And Co., Ltd. |
Solid preparations with improved absorbability of hardly water-soluble drug
|
NZ519363A
(en)
*
|
2002-06-05 |
2004-02-27 |
Agres Ltd |
A novel drug dosing regimen
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
MY142204A
(en)
|
2002-07-25 |
2010-10-29 |
Pharmacia Corp |
Pramipexole once-daily dosage form
|
US20060039974A1
(en)
|
2002-09-11 |
2006-02-23 |
Takeda Pharmaceutical Company Limited |
Sustained release preparation
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
JP4459543B2
(ja)
|
2003-03-17 |
2010-04-28 |
株式会社メドジェル |
徐放性ハイドロゲル製剤
|
WO2005011635A2
(en)
|
2003-08-04 |
2005-02-10 |
Pfizer Products Inc. |
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8128958B2
(en)
|
2003-11-10 |
2012-03-06 |
Astellas Pharma Inc. |
Sustained release pharmaceutical composition
|
US8197846B2
(en)
|
2003-11-10 |
2012-06-12 |
Astellas Pharma Inc. |
Sustained release pharmaceutical composition
|
US20050171248A1
(en)
*
|
2004-02-02 |
2005-08-04 |
Yanmei Li |
Hydrogel for use in downhole seal applications
|
WO2005079752A2
(en)
*
|
2004-02-11 |
2005-09-01 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
SI1765292T1
(en)
|
2004-06-12 |
2018-04-30 |
Collegium Pharmaceutical, Inc. |
Formulations of medicines to discourage abuse
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
WO2006015277A1
(en)
*
|
2004-07-30 |
2006-02-09 |
Baker Hughes Incorporated |
Downhole inflow control device with shut-off feature
|
EP1781260B2
(de)
|
2004-08-13 |
2014-04-02 |
Boehringer Ingelheim International GmbH |
Tablettenformulierung mit verlängerter freisetzung enthaltend pramipexol oder ein pharmazeutisch annehmbares salz, die herstellungsmethode und die verwendung der tabletten
|
MX2007001850A
(es)
|
2004-08-13 |
2007-03-28 |
Boehringer Ingelheim Int |
Formulacion de pildora de liberacion prolongada que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para fabricarlo y uso del mismo.
|
US20060074182A1
(en)
|
2004-09-30 |
2006-04-06 |
Depuy Products, Inc. |
Hydrogel composition and methods for making the same
|
CA2582615A1
(en)
*
|
2004-10-05 |
2006-04-13 |
Astellas Pharma Inc. |
Pharmaceutical composition for treatment of tear and salivary fluid drying
|
JP2008523143A
(ja)
*
|
2004-12-13 |
2008-07-03 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
月経困難症の治療のためのα−アドレナリン遮断剤の使用
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20060239956A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Lulu Henson |
Preparation and use of hydrogels
|
KR20080055797A
(ko)
*
|
2005-08-23 |
2008-06-19 |
닛산 가가쿠 고교 가부시키 가이샤 |
서방성 제제
|
WO2007055329A1
(ja)
*
|
2005-11-11 |
2007-05-18 |
Asahi Kasei Chemicals Corporation |
徐放性固形製剤
|
GB0607534D0
(en)
*
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
EP2026766A1
(de)
|
2006-05-17 |
2009-02-25 |
Synthon B.V. |
Tabletten-zusammensetzung mit verlängerter freisetzung von tamsulosin
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
EP2090298A4
(de)
*
|
2006-11-13 |
2014-02-26 |
Kyorin Seiyaku Kk |
Verfahren zur herstellung einer tablette mit verzögerter freisetzung
|
WO2008081829A1
(ja)
|
2006-12-27 |
2008-07-10 |
Astellas Pharma Inc. |
難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーe
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
US8312931B2
(en)
*
|
2007-10-12 |
2012-11-20 |
Baker Hughes Incorporated |
Flow restriction device
|
US7942206B2
(en)
|
2007-10-12 |
2011-05-17 |
Baker Hughes Incorporated |
In-flow control device utilizing a water sensitive media
|
EP2047847A1
(de)
|
2007-10-12 |
2009-04-15 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Feste pharmazeutische Zusammensetzung mit Tamsulosin
|
US8096351B2
(en)
*
|
2007-10-19 |
2012-01-17 |
Baker Hughes Incorporated |
Water sensing adaptable in-flow control device and method of use
|
US8069921B2
(en)
*
|
2007-10-19 |
2011-12-06 |
Baker Hughes Incorporated |
Adjustable flow control devices for use in hydrocarbon production
|
US7775271B2
(en)
|
2007-10-19 |
2010-08-17 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7784543B2
(en)
*
|
2007-10-19 |
2010-08-31 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7918272B2
(en)
*
|
2007-10-19 |
2011-04-05 |
Baker Hughes Incorporated |
Permeable medium flow control devices for use in hydrocarbon production
|
US7913755B2
(en)
|
2007-10-19 |
2011-03-29 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US20090101354A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Baker Hughes Incorporated |
Water Sensing Devices and Methods Utilizing Same to Control Flow of Subsurface Fluids
|
US7891430B2
(en)
|
2007-10-19 |
2011-02-22 |
Baker Hughes Incorporated |
Water control device using electromagnetics
|
US7775277B2
(en)
*
|
2007-10-19 |
2010-08-17 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7913765B2
(en)
*
|
2007-10-19 |
2011-03-29 |
Baker Hughes Incorporated |
Water absorbing or dissolving materials used as an in-flow control device and method of use
|
US7793714B2
(en)
|
2007-10-19 |
2010-09-14 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7789139B2
(en)
|
2007-10-19 |
2010-09-07 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US8544548B2
(en)
*
|
2007-10-19 |
2013-10-01 |
Baker Hughes Incorporated |
Water dissolvable materials for activating inflow control devices that control flow of subsurface fluids
|
US20090101344A1
(en)
*
|
2007-10-22 |
2009-04-23 |
Baker Hughes Incorporated |
Water Dissolvable Released Material Used as Inflow Control Device
|
US7918275B2
(en)
*
|
2007-11-27 |
2011-04-05 |
Baker Hughes Incorporated |
Water sensitive adaptive inflow control using couette flow to actuate a valve
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
US7597150B2
(en)
|
2008-02-01 |
2009-10-06 |
Baker Hughes Incorporated |
Water sensitive adaptive inflow control using cavitations to actuate a valve
|
US8839849B2
(en)
*
|
2008-03-18 |
2014-09-23 |
Baker Hughes Incorporated |
Water sensitive variable counterweight device driven by osmosis
|
US7992637B2
(en)
*
|
2008-04-02 |
2011-08-09 |
Baker Hughes Incorporated |
Reverse flow in-flow control device
|
DE102008022520A1
(de)
*
|
2008-05-07 |
2009-11-12 |
Bayer Animal Health Gmbh |
Feste Arzneimittelformulierung mit verzögerter Freisetzung
|
US8931570B2
(en)
*
|
2008-05-08 |
2015-01-13 |
Baker Hughes Incorporated |
Reactive in-flow control device for subterranean wellbores
|
HUE030803T2
(en)
|
2008-05-09 |
2017-06-28 |
Gruenenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
|
US7789152B2
(en)
|
2008-05-13 |
2010-09-07 |
Baker Hughes Incorporated |
Plug protection system and method
|
US8171999B2
(en)
*
|
2008-05-13 |
2012-05-08 |
Baker Huges Incorporated |
Downhole flow control device and method
|
US8555958B2
(en)
|
2008-05-13 |
2013-10-15 |
Baker Hughes Incorporated |
Pipeless steam assisted gravity drainage system and method
|
US8113292B2
(en)
|
2008-05-13 |
2012-02-14 |
Baker Hughes Incorporated |
Strokable liner hanger and method
|
US7762341B2
(en)
*
|
2008-05-13 |
2010-07-27 |
Baker Hughes Incorporated |
Flow control device utilizing a reactive media
|
EP2161019A1
(de)
|
2008-09-05 |
2010-03-10 |
KRKA, D.D., Novo Mesto |
Verlängerte Freisetzung von einer pharmazeutischen Mehrteilchenzusammensetzung mit Paliperidon
|
TWI478712B
(zh)
|
2008-09-30 |
2015-04-01 |
Astellas Pharma Inc |
釋控性醫藥組成物
|
US8465770B2
(en)
|
2008-12-24 |
2013-06-18 |
Synthon Bv |
Low dose controlled release tablet
|
CN102307579B
(zh)
|
2009-02-04 |
2013-10-16 |
安斯泰来制药株式会社 |
经口给药用医药组合物
|
EP2255793A1
(de)
|
2009-05-28 |
2010-12-01 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Pharmazeutische Zusammensetzung mit Tamsulosin
|
US8056627B2
(en)
*
|
2009-06-02 |
2011-11-15 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints and method
|
US20100300674A1
(en)
*
|
2009-06-02 |
2010-12-02 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US8132624B2
(en)
*
|
2009-06-02 |
2012-03-13 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints and method
|
US20100300675A1
(en)
*
|
2009-06-02 |
2010-12-02 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US8151881B2
(en)
*
|
2009-06-02 |
2012-04-10 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
EP2456427B1
(de)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Heißschmelzextrudierte retardierte pharmazeutische Darreichungsform
|
AR077420A1
(es)
|
2009-07-22 |
2011-08-24 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion
|
CA2780294C
(en)
|
2009-11-09 |
2018-01-16 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
WO2011057133A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
EP2531176B1
(de)
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels eines extruders
|
CA2788659C
(en)
*
|
2010-02-24 |
2015-05-05 |
Pfizer Inc. |
Veterinary compositions
|
JP5849946B2
(ja)
*
|
2010-03-29 |
2016-02-03 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
PL2554168T3
(pl)
|
2010-03-29 |
2018-05-30 |
Astellas Pharma Inc. |
Kompozycja farmaceutyczna do kontrolowanego uwalniania
|
JP5933553B2
(ja)
|
2010-09-02 |
2016-06-15 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
アニオン性ポリマーを含む不正使用抵抗性剤形
|
ES2486791T3
(es)
|
2010-09-02 |
2014-08-19 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
|
US9011912B2
(en)
|
2010-10-07 |
2015-04-21 |
Abon Pharmaceuticals, Llc |
Extended-release oral dosage forms for poorly soluble amine drugs
|
EA032906B1
(ru)
|
2010-12-22 |
2019-08-30 |
Пэдью Фарма Л.П. |
Твердая лекарственная форма с контролируемым высвобождением и способы ее получения и применения
|
KR101458334B1
(ko)
|
2010-12-23 |
2014-11-04 |
퍼듀 퍼머 엘피 |
탬퍼 저항성 고체 경구 투여 형태
|
KR102027912B1
(ko)
|
2011-02-15 |
2019-10-02 |
지엘팜텍주식회사 |
경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
|
RU2451680C1
(ru)
|
2011-02-21 |
2012-05-27 |
Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" |
Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
|
KR101992449B1
(ko)
*
|
2011-06-07 |
2019-06-24 |
젤레시스 엘엘씨 |
하이드로겔 생성 방법
|
LT2736495T
(lt)
|
2011-07-29 |
2017-11-10 |
Grünenthal GmbH |
Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
|
RS56527B1
(sr)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
|
CA2852417A1
(en)
*
|
2011-10-21 |
2013-04-25 |
Takeda Pharmaceutical Company Limited |
Sustained-release preparation
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
JP6123795B2
(ja)
*
|
2012-03-30 |
2017-05-10 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
EP2838512B1
(de)
|
2012-04-18 |
2018-08-22 |
Grünenthal GmbH |
Fälschungssichere und dose dumping sichere pharmazeutische darreichungsform
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
WO2014096181A1
(en)
*
|
2012-12-21 |
2014-06-26 |
Nestec S.A. |
Device for producing milk foam
|
US8999393B1
(en)
|
2013-01-09 |
2015-04-07 |
Edgemont Pharmaceuticals Llc |
Sustained release formulations of lorazepam
|
CN105120846B
(zh)
|
2013-02-05 |
2019-10-18 |
普渡制药公司 |
抗篡改的药物制剂
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
|
EP3003297A4
(de)
|
2013-06-05 |
2017-04-19 |
Synchroneuron Inc. |
Acamprosat-formulierungen, verfahren zur verwendung davon und kombinationen damit
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
EP3073994A1
(de)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels kryogenen mahlens
|
EP3142646A1
(de)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Manipulationssichere kapselformulierung mit tapentadol mit unmittelbarer freisetzung
|
AU2015266117A1
(en)
|
2014-05-26 |
2016-11-24 |
Grunenthal Gmbh |
Multiparticles safeguarded against ethanolic dose-dumping
|
JP6726109B2
(ja)
|
2014-06-20 |
2020-07-22 |
ジェレシス,エルエルシー |
過体重または肥満を治療するための組成物
|
ES2858517T3
(es)
|
2014-11-07 |
2021-09-30 |
Sublimity Therapeutics Ltd |
Composiciones que comprenden ciclosporina
|
MX2017009805A
(es)
|
2015-01-29 |
2018-05-07 |
Gelesis Llc |
Método para la producción de hidrogeles que juntan alto módulo elástico y absorbancia.
|
WO2016123482A2
(en)
|
2015-01-30 |
2016-08-04 |
Mylan, Inc. |
Sustained-release oral dosage forms for low aqueous solubility compounds
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
TWI722988B
(zh)
*
|
2015-06-05 |
2021-04-01 |
瑩碩生技醫藥股份有限公司 |
緩釋性醫藥組合物及其製備方法
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
US9687475B1
(en)
|
2016-03-24 |
2017-06-27 |
Ezra Pharma Llc |
Extended release pharmaceutical formulations with controlled impurity levels
|
US9675585B1
(en)
|
2016-03-24 |
2017-06-13 |
Ezra Pharma |
Extended release pharmaceutical formulations
|
CN105770866A
(zh)
*
|
2016-04-08 |
2016-07-20 |
王夕花 |
一种缓释型降糖药物组合物及其制备方法
|
US10543174B2
(en)
|
2016-04-25 |
2020-01-28 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
WO2017189422A1
(en)
|
2016-04-25 |
2017-11-02 |
Gelesis, Llc. |
Method for treating constipation
|
US20190307696A1
(en)
|
2016-04-25 |
2019-10-10 |
Synthon B.V. |
Tablets comprising mirabegron and solifenacin
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
EP3292864A1
(de)
|
2017-10-12 |
2018-03-14 |
Synthon B.V. |
Tablettenzusammensetzung aus mirabegron mit modifizierter freisetzung
|
WO2019072404A1
(en)
|
2017-10-12 |
2019-04-18 |
Synthon B.V. |
MODIFIED RELEASE COMPRESSED COMPOSITION COMPRISING MIRABEGRON
|
US10478399B2
(en)
|
2017-10-12 |
2019-11-19 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
EP4035660A1
(de)
|
2017-10-17 |
2022-08-03 |
Synthon B.V. |
Tabletten mit tamsulosin und solifenacin
|
TW202140010A
(zh)
*
|
2020-01-31 |
2021-11-01 |
日商日本新藥股份有限公司 |
控釋組合物
|
WO2022117594A1
(en)
|
2020-12-01 |
2022-06-09 |
Adamed Pharma S.A. |
Orally-administered preparation containing solifenacin and tamsulosin
|
JP2023553202A
(ja)
|
2020-12-08 |
2023-12-20 |
ルミナント バイオテク コーポレーション リミテッド |
動物に物質を送達するための装置および方法の改善
|